المؤلفون: Dirk Schadendorf, Carola Berking, Lisa Zimmer, Ralf Gutzmer, Alexander Kreuter, Andrea Forschner, Elisabeth Livingstone, Bastian Schilling, Selma Ugurel, Peter Mohr, Jessica Hassel, Patrick Terheyden, Henner Stege, Katharina Kaehler, Sebastian Haferkamp, Friedegund Meier, Claudia Pfoehler, Dirk Debus, Rudolf Herbst, Carmen Loquai, Frank Meiss, Martin Kaatz, Jens Ulrich, Edgar Dippel, Michael Weichenthal, Ulrike Leiter, Markus V Heppt, Michael Sachse, Fabian Ziller, Stephan Grabbe, Georg Lodde, Maximilian Haist, Friederike Rogall, Yuqi Tan, Kai Christian Klespe, Michael Tronnier, Imke von Wasielewski, Felix Kieker, Christopher Gebhardt, Jan Simon

المصدر: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2051-1426Test

الوصول الحر: https://doaj.org/article/85987b665cf74916884422bf2059f401Test

المؤلفون: Juliane Weilandt, Katharina Diehl, Marthe Lisa Schaarschmidt, Felix Kieker, Bianca Sasama, Melanie Pronk, Jan Ohletz, Andreas Könnecke, Verena Müller, Jochen Utikal, Uwe Hillen, Wolfgang Harth, Wiebke K. Peitsch

المصدر: Acta Dermato-Venereologica, Vol 100, Iss 6, p adv00083 (2020)

مصطلحات موضوعية: patient preferences, conjoint analysis, melanoma, targeted therapy, braf inhibitors, immune checkpoint inhibitors, Dermatology, RL1-803

وصف الملف: electronic resource

العلاقة: https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3422Test; https://doaj.org/toc/0001-5555Test; https://doaj.org/toc/1651-2057Test

الوصول الحر: https://doaj.org/article/0cc08fefb2474e88985559a7505e4cafTest

المؤلفون: Wolfgang Harth, Bianca Sasama, Verena Müller, Uwe Hillen, Jan Ohletz, Wiebke K. Peitsch, Felix Kieker, Marthe Lisa Schaarschmidt, Juliane Weilandt, Andreas Könnecke, Jochen Utikal, Melanie Pronk, Katharina Diehl

المصدر: Acta Dermato-Venereologica, Vol 100, Iss 6, p adv00083 (2020)

مصطلحات موضوعية: Oncology, Male, Skin Neoplasms, medicine.medical_treatment, Herpesvirus 1, Human, Choice Behavior, Targeted therapy, 030207 dermatology & venereal diseases, 0302 clinical medicine, braf inhibitors, Medicine, 030212 general & internal medicine, Immune Checkpoint Inhibitors, Melanoma, Aged, 80 and over, Drug Administration Routes, Palliative Care, Age Factors, Patient Preference, General Medicine, Middle Aged, targeted therapy, MAP Kinase Kinase Kinases, Patient preference, Progression-Free Survival, Survival Rate, Chemotherapy, Adjuvant, RL1-803, conjoint analysis, Educational Status, Female, Adjuvant, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Dermatology, Drug Administration Schedule, 03 medical and health sciences, Route of administration, Young Adult, Internal medicine, Humans, Adverse effect, Survival rate, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Biological Products, business.industry, medicine.disease, Discontinuation, business, patient preferences

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e78d0a48e70e8b37876c3e729df309Test
https://pubmed.ncbi.nlm.nih.gov/32057087Test

المؤلفون: Michael Fluck, Patrick Terheyden, Peter Mohr, Beate Conrad, Carmen Loquai, Bastian Schilling, Christine Windemuth-Kieselbach, Friedegund Meier, Christian Menzer, Felix Kieker, Silvia Körner, Jochen Utikal, Rudolf A. Herbst, Alexander Rösch, Thomas Eigentler, Carola Berking, Axel Hauschild, Jessica C. Hassel, Dirk Schadendorf, Edgar Dippel, Lisa Zimmer, Jürgen C. Becker, Uwe M. Martens, Rudolf Stadler, Leonora Schwarz, Elisabeth Livingstone, Sabine Sell, Sebastian Haferkamp, Ralf Gutzmer, Claus Garbe, Jan-Christoph Simon

المصدر: Lancet (London, England). 395(10236)

مصطلحات موضوعية: medicine.medical_specialty, Skin Neoplasms, Population, Medizin, Ipilimumab, 030204 cardiovascular system & hematology, Placebo, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Adjuvants, Immunologic, Double-Blind Method, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Adjuvant therapy, Medicine, Humans, 030212 general & internal medicine, Progression-free survival, education, Melanoma, Aged, Neoplasm Staging, education.field_of_study, business.industry, General Medicine, Middle Aged, Interim analysis, Progression-Free Survival, Nivolumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd0e8a8f5cae4bc6aab1b99e6a7d3a0Test
https://pubmed.ncbi.nlm.nih.gov/32472086Test